Amsino, A Strong Force in the Fight Against COVID-19

How a medical device company supported the frontlines through innovation during COVID-19

While COVID-19 came as a surprise for many and continues to wreak havoc across communities and businesses in the U.S., one medical device company was ready to assist in fighting off the pandemic. “COVID-19 has been a wake-up call across the world,” says Richard Lee, founder and CEO of Amsino International Inc., a medical device company founded in California in 1993. “I just saw a need for technological innovation and new methods for stopping the spread of infectious diseases, and our company mission is just that: improving the safety and efficacy of patient care.”

[Read More]

Dear Valued Customers

As COVID-19 (Coronavirus) spread escalates globally, I wanted to reach out and let you know how Amsino is handling this unprecedented crisis. We at Amsino are committed to the continuity of serving our customers, while at the same time ensuring the health and wellness of our employees.

On January 28, 2020, we established a COVID-19 task force. We have since put many precautionary measures into action aiming at protecting our employees and minimizing the impact on our customers. 

[Read More]


Since the beginning of the COVID-19 viral outbreak, Amsino has actively joined in the fight against the coronavirus outbreak. Upholding its strong sense of social responsibilities and professionalism, Amsino has donated 1 million RMB in medical products directly to many hospitals in Wuhan, Hubei Province, Shanghai, and Jiangsu areas. 

[Read More]

Interview with Dr. Richard Y. Lee, Founder, Chairman & CEO of Amsino Medical Group

Dr. Richard Y. Lee, Founder, Chairman and CEO Amsino Medical Group, told the journalist that AMSINO was founded in 1993 and headquartered in California as a multinational medical device company that integrates R&D, manufacturing and global sales and marketing. It has 2000 employees working in 6 business divisions and 5 factories. Amsino Medical Group is aimed to improve healthcare by enhancing the safety and efficacy of patient care. It has obtained over 100 patents of internationally leading medical technologies. AMSINO medical products mainly cover: medication delivery systems, enteral nutrition feeding systems, RECEPTAL and iRECEPTAL waste fluid management systems, urological care, respiratory therapy systems, and surgical and nursing solutions. AMSINO medical products are distributed in more than 80 countries around the world besides the US. He said, "This year marks the 25th anniversary of the founding of AMSINO. Our company has undergone great changes in R&D, manufacturing and globalization. We have six business divisions, which are North America Business Division, Latin America Business Division, Europe, Middle East and Africa Business Division, Asia Pacific Business Division, China Business Division, and Contract Manufacturing Business Division. Among them, the US supports sales in North America and Latin America, Amsterdam of Netherlands supports sales in Europe, Middle East and Africa, and Shanghai of China supports sales in Asia Pacific, including Greater China Region. We attach great importance to the Chinese market which is a strategic market with unlimited business opportunities and great potential for growth. At present, our business in China accounts for about 15% of the total sales volume of the company."

[Read More]